Skip to Navigation
Skip to Main Content
Skip to Related Content

Advertisement

U.S. Markets closed

S&P 500
5,808.12
-1.74(-0.03%)
Dow 30
42,114.40
-259.96(-0.61%)
Nasdaq
18,518.61
+103.12(+0.56%)
Russell 2000
2,207.99
-10.93(-0.49%)
Crude Oil
71.69
+1.50(+2.14%)
Gold
2,760.80
+11.90(+0.43%)

Evome Medical Technologies Inc. (EVMT.V)

TSXV - TSXV Real Time Price. Currency in CAD

Follow

0.1100

-0.0100

(-8.33%)

At close: 03:58PM EDT

Currency in CAD

Valuation Measures⁴

Market Cap (intraday)	9.10M
Enterprise Value	27.41M
Trailing P/E	23.70
Forward P/E	N/A
PEG Ratio (5 yr expected)	N/A
Price/Sales (ttm)	0.16
Price/Book (mrq)	2.56
Enterprise Value/Revenue	0.47
Enterprise Value/EBITDA	-2.61

Trading Information

Stock Price History

Beta (5Y Monthly)	1.90
52-Week Change ³	N/A
S&P500 52-Week Change ³	N/A
52 Week High ³	0.3000
52 Week Low ³	0.0800
50-Day Moving Average ³	0.1411
200-Day Moving Average ³	0.1686

Share Statistics

Avg Vol (3 month) ³	76.53k
Avg Vol (10 day) ³	115.94k
Shares Outstanding ⁵	59.81M
Implied Shares Outstanding ⁶	N/A
Float ⁸	54.21M
% Held by Insiders ¹	15.73%
% Held by Institutions ¹	9.94%
Shares Short (Oct 15, 2024) ⁴	652
Short Ratio (Oct 15, 2024) ⁴	0.01
Short % of Float (Oct 15, 2024) ⁴	N/A
Short % of Shares Outstanding (Oct 15, 2024) ⁴	0.00%
Shares Short (prior month Sep 13, 2024) ⁴	2.85k

Dividends & Splits

Forward Annual Dividend Rate ⁴	N/A
Forward Annual Dividend Yield ⁴	N/A
Trailing Annual Dividend Rate ³	0.00
Trailing Annual Dividend Yield ³	0.00%
5 Year Average Dividend Yield ⁴	N/A
Payout Ratio ⁴	0.00%
Dividend Date ³	Dec 14, 2020
Ex-Dividend Date ⁴	May 24, 2017
Last Split Factor ²	N/A
Last Split Date ³	N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends	Dec 31, 2023
Most Recent Quarter (mrq)	Jun 30, 2024

Profitability

Profit Margin	-35.36%
Operating Margin (ttm)	-17.50%

Management Effectiveness

Return on Assets (ttm)	-35.78%
Return on Equity (ttm)	-289.79%

Income Statement

Revenue (ttm)	54.86M
Revenue Per Share (ttm)	0.65
Quarterly Revenue Growth (yoy)	-38.00%
Gross Profit (ttm)	N/A
EBITDA	N/A
Net Income Avi to Common (ttm)	-19.39M
Diluted EPS (ttm)	-0.2400
Quarterly Earnings Growth (yoy)	N/A

Balance Sheet

Total Cash (mrq)	1.07M
Total Cash Per Share (mrq)	0.01
Total Debt (mrq)	19.39M
Total Debt/Equity (mrq)	N/A
Current Ratio (mrq)	0.55
Book Value Per Share (mrq)	-0.03

Cash Flow Statement

Operating Cash Flow (ttm)	3.51M
Levered Free Cash Flow (ttm)	N/A